
Regeneron reports COVID-19 antibody cocktail reduced infection risk by 82% for 8 months — so far
Fox News
Biotech giant Regeneron has claimed that its antibody cocktail reduces the risk of COVID-19 infection by nearly 82% for eight months.
"During the 8-month assessment period, there were 0 hospitalizations for COVID-19 in the REGEN-COV group and 6 in the placebo group," Regeneron said in a press release. "The fully human antibodies in REGEN-COV were developed to provide long-lasting protective effects without any artificial mutations or sequences."
No deaths occurred either.
More Related News